Lataa...
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
One hundred and seventy-five children with Stage 3 or 4 neuroblastoma who had obtained a good response to conventional therapy were randomly allocated to 13-Cis retinoic acid at a dose of 0.75 mg/kg/day or placebo for up to 4 years. Toxicity was mild but no advantage in event-free survival was shown...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2000
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363577/ https://ncbi.nlm.nih.gov/pubmed/11027423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1425 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|